List of Intron Biotechnology Inc. patents

Patents where

Current Assignee

Name

Intron Biotechnology Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11324841 Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity	Patent 11324841 was granted and assigned to Intron Biotechnology Inc. on May, 2022 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	11324841	May 10, 2022
‌ US Patent 10265356 Enteroinvasive	Patent 10265356 was granted and assigned to Intron Biotechnology Inc. on April, 2019 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10265356	April 23, 2019
‌ US Patent 10265353 Enterohemorrhagic	Patent 10265353 was granted and assigned to Intron Biotechnology Inc. on April, 2019 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10265353	April 23, 2019
‌ US Patent 10265354 Enteropathogenic	Patent 10265354 was granted and assigned to Intron Biotechnology Inc. on April, 2019 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10265354	April 23, 2019
‌ US Patent 10028984 Clostridium perfringens bacteriophage Clo-PEP-1 and use thereof for inhibiting proliferation of clostridium perfringens	Patent 10028984 was granted and assigned to Intron Biotechnology Inc. on July, 2018 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10028984	July 24, 2018
‌ US Patent 10265355 Shigatoxin-producing F18 type	Patent 10265355 was granted and assigned to Intron Biotechnology Inc. on April, 2019 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10265355	April 23, 2019
‌ US Patent 10894068 None	Patent 10894068 was granted and assigned to Intron Biotechnology Inc. on January, 2021 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10894068	January 19, 2021
‌ US Patent 11351210 None	Patent 11351210 was granted and assigned to Intron Biotechnology Inc. on June, 2022 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	11351210	June 7, 2022
‌ US Patent 10227570 None	Patent 10227570 was granted and assigned to Intron Biotechnology Inc. on March, 2019 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10227570	March 12, 2019
‌ US Patent 10227571 None	Patent 10227571 was granted and assigned to Intron Biotechnology Inc. on March, 2019 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10227571	March 12, 2019
‌ US Patent 10226060 Lactococcus garvieae bacteriophage Lac-GAP-1 and use thereof in suppressing proliferation of lactococcus garvieae bacteria	Patent 10226060 was granted and assigned to Intron Biotechnology Inc. on March, 2019 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10226060	March 12, 2019
‌ US Patent 10898531 None	Patent 10898531 was granted and assigned to Intron Biotechnology Inc. on January, 2021 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10898531	January 26, 2021
‌ US Patent 11219698 Metal oxide nanoparticle-based T1-T2 dual-mode magnetic resonance imaging contrast agent	Patent 11219698 was granted and assigned to Intron Biotechnology Inc. on January, 2022 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	11219698	January 11, 2022
‌ US Patent 10618934 Peptide compound, production method therefor, and use thereof		Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10618934	April 14, 2020
‌ US Patent 10759831 Peptide compound, production method therefor, and use thereof		Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10759831	September 1, 2020
‌ US Patent 10941172 Chemical method for preparing heme iron not derived from porcine blood	Patent 10941172 was granted and assigned to Intron Biotechnology Inc. on March, 2021 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10941172	March 9, 2021
‌ US Patent 10751377 Vibrio parahaemolyticus bacteriophage Vib-PAP-1 and use thereof for inhibiting proliferation of vibrio parahaemolyticus		Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10751377	August 25, 2020
‌ US Patent 10722544 None		Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10722544	July 28, 2020
‌ US Patent 11020442 Vibrio parahaemolyticus bacteriophage Vib-PAP-2 and use thereof for inhibiting proliferation of	Patent 11020442 was granted and assigned to Intron Biotechnology Inc. on June, 2021 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	11020442	June 1, 2021
‌ US Patent 9505779 Tacrolimus analogues, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same	Patent 9505779 was granted and assigned to Intron Biotechnology Inc. on November, 2016 by the United States Patent and Trademark Office.		Intron Biotechnology Inc.	United States Patent and Trademark Office	9505779	November 29, 2016
‌ US Patent 10696989 Biological method for preparing heme iron not derived from porcine blood		Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10696989	June 30, 2020
‌ US Patent 10568917 None	Patent 10568917 was granted and assigned to Intron Biotechnology Inc. on February, 2020 by the United States Patent and Trademark Office.	Intron Biotechnology Inc.	Intron Biotechnology Inc.	United States Patent and Trademark Office	10568917	February 25, 2020

22 results

0 selected

22 results

0 selected